跳至主要内容
临床试验/CTRI/2023/09/057178
CTRI/2023/09/057178尚未招募4 期

A comparative study on safety and efficacy of intralesional tranexamic acid versus 50% glycolic acid chemical peel in the treatment of melasma

Madeshwari M1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年8月9日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
To assess the resolution of hyperpigmentation

研究概览

简要总结

Melasma is a common acquired hyperpigmentation disorder, various treatment modalities are available

Management is difficult because it’s frequent relapse.

Recently studies shows  intralesional tranexamic acid a hemostatic agent,has hypopigmentary effect on melasma lesions

Hence, my aim of study is to compare safety and efficacy of intralesional tranexamic acid versus 50%glycolic acid chemical peel

研究设计

研究类型
Interventional
分配方式
Random Number Table
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients willing to participate in the study.

排除标准

  • Before starting the study Pregnant & lactating mothers Patients on oral contraceptive pills, hormonal replacement therapy Active infection /inflammationPhotosensitivity disorders (SLE, porphyria) History of bleeding disorder /Anticoagulant treatment History of allergy Any other mode of treatment for melasma prior to the study During the Study: Develops side effects during the treatment patient wants to discontinue the treatment.

结局指标

主要结局

To assess the resolution of hyperpigmentation

时间窗: Baseline,week 4, week 8, week 12 and week 24

次要结局

  • To assess modified MASI score(Baseline, week 12 and week 24)

研究者

发起方
Madeshwari M
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验